4.7 Article

Synthesis and biological evaluation of novel quinazoline-4-piperidinesulfamide derivatives as inhibitors of NPP1

期刊

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 147, 期 -, 页码 130-149

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2018.01.094

关键词

NPP1 inhibitor; Quinazoline; Sulfamide; Calcific aortic valve disease

资金

  1. Natural Sciences and Engineering Research Council of Canada (NSERC)
  2. Fonds de recherche sur la nature et les technologies (FRQNT)
  3. FRQNT Research Network on Protein Function, Structure and Engineering (PROTEO)
  4. Heart and Stroke Foundation of Canada
  5. Universite Laval

向作者/读者索取更多资源

The ecto-nucleotide pyrophosphatase/phosphodiesterase-1 (NPP1) was recently shown to promote mineralization of the aortic valve, hence, its inhibition represents a significant target. A quinazoline-4. piperidine sulfamide compound (QPS1) has been described as a specific and non-competitive inhibitor of NPP1. We report herein the synthesis and in vitro inhibition studies of novel quinazoline-4-piperidinc sulfamide analogues using QPS1 as the lead compound. Of the 26 derivatives prepared, four compound were found to have K-i < 105 nM against human NPP1. (C) 2018 Elsevier Masson SAS. All rights reserved

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据